First Heartland Consultants’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$754K Buy
5,871
+32
+0.5% +$3.75K 0.05% 257
2026
Q1
$702K Buy
5,839
+75
+1% +$8.66K 0.05% 237
2025
Q4
$607K Buy
5,764
+3
+0.1% +$282 0.05% 254
2025
Q3
$484K Buy
5,761
+62
+1% +$5.11K 0.04% 290
2025
Q2
$451K Sell
5,699
-1,349
-19% -$107K 0.04% 290
2025
Q1
$633K Sell
7,048
-474
-6% -$44.3K 0.07% 200
2024
Q4
$748K Sell
7,522
-148
-2% -$15.3K 0.08% 181
2024
Q3
$871K Sell
7,670
-352
-4% -$41.8K 0.09% 154
2024
Q2
$993 Sell
8,022
-43
-0.5% -$5.54K 0.07% 174
2024
Q1
$1.06M Buy
8,065
+13
+0.2% +$1.6K 0.11% 159
2023
Q4
$878K Sell
8,052
-1,471
-15% -$153K 0.11% 154
2023
Q3
$980K Buy
9,523
+224
+2% +$24.1K 0.12% 145
2023
Q2
$1.07M Sell
9,299
-335
-3% -$38K 0.14% 133
2023
Q1
$1.02M Sell
9,634
-1,225
-11% -$132K 0.15% 132
2022
Q4
$1.2M Sell
10,859
-11,379
-51% -$1.16M 0.19% 115
2022
Q3
$1.92K Sell
22,238
-2,292
-9% -$205K 0.16% 87
2022
Q2
$2.24M Buy
24,530
+10,485
+75% +$930K 0.35% 70
2022
Q1
$1.15M Buy
14,045
+3,047
+28% +$240K 0.18% 101
2021
Q4
$842 Sell
10,998
-863
-7% -$68.7K 0.03% 133
2021
Q3
$891K Sell
11,861
-3,411
-22% -$259K 0.14% 144
2021
Q2
$1.19M Sell
15,272
-784
-5% -$58.3K 0.18% 120
2021
Q1
$1.18M Buy
16,056
+6,660
+71% +$491K 0.19% 113
2020
Q4
$733K Buy
9,396
+283
+3% +$21.6K 0.12% 126
2020
Q3
$721K Buy
9,113
+14
+0.2% +$1.1K 0.14% 116
2020
Q2
$671K Buy
9,099
+128
+1% +$9.64K 0.13% 128
2020
Q1
$659K Buy
8,971
+961
+12% +$75.5K 0.17% 111
2019
Q4
$695K Buy
8,010
+135
+2% +$11.1K 0.14% 145
2019
Q3
$633K Buy
7,875
+181
+2% +$14.5K 0.14% 139
2019
Q2
$616K Buy
7,694
+588
+8% +$45K 0.15% 130
2019
Q1
$564K Buy
7,106
+2,573
+57% +$192K 0.16% 135
2018
Q4
$330K Sell
4,533
-368
-8% -$26K 0.12% 163
2018
Q3
$332K Sell
4,901
-103
-2% -$6.56K 0.1% 177
2018
Q2
$290K Sell
5,004
-2,292
-31% -$129K 0.1% 189
2018
Q1
$379K Sell
7,296
-716
-9% -$38.7K 0.11% 188
2017
Q4
$430K Sell
8,012
-16,950
-68% -$940K 0.13% 173
2017
Q3
$1.52M Sell
24,962
-127
-0.5% -$7.7K 0.37% 73
2017
Q2
$1.53M Sell
25,089
-280
-1% -$17K 0.4% 66
2017
Q1
$1.54M Sell
25,369
-126
-0.5% -$7.64K 0.43% 63
2016
Q4
$1.43M Buy
25,495
+394
+2% +$23.1K 0.43% 61
2016
Q3
$1.5M Sell
25,101
-300
-1% -$17.5K 0.43% 56
2016
Q2
$1.4K Buy
25,401
+1,136
+5% +$60.5K 0.15% 56
2016
Q1
$1.23M Buy
24,265
+408
+2% +$20K 0.47% 46
2015
Q4
$1.2M Buy
23,857
+13
+0.1% +$655 0.46% 55
2015
Q3
$1.12M Buy
23,844
+651
+3% +$34.6K 0.47% 53
2015
Q2
$1.26K Sell
23,193
-66
-0.3% -$3.7K 0.34% 54
2015
Q1
$1.28M Sell
23,259
-356
-2% -$20.2K 0.49% 52
2014
Q4
$1.28M Sell
23,615
-91
-0.4% -$5.07K 0.53% 49
2014
Q3
$1.34M Sell
23,706
-8,016
-25% -$450K 0.59% 43
2014
Q2
$1.75M Buy
31,722
+95
+0.3% +$5.18K 0.79% 31
2014
Q1
$1.71M Buy
31,627
+927
+3% +$48K 0.84% 27
2013
Q4
$1.47M Buy
30,700
+1,260
+4% +$57.6K 0.83% 30
2013
Q3
$1.37M Buy
29,440
+10,962
+59% +$500K 0.83% 29
2013
Q2
$819K Buy
+18,478
New +$825K 0.48% 56

Other funds holding MRK

First Heartland Consultants's MRK Position: Q2 2026 in Review

First Heartland Consultants increased its Merck (MRK) stake by 0.55% in Q2 2026, buying an estimated $3.75K and bringing the position to 5,871 shares worth $754K. The position accounts for 0.05% of the portfolio, ranked #257.

First Heartland Consultants first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.24M in Q2 2022. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • First Heartland Consultants held 5,871 shares of Merck worth $754K as of Q2 2026.
  • First Heartland Consultants bought 32 Merck shares in Q2 2026, an estimated $3.75K.
  • Merck made up 0.05% of First Heartland Consultants's portfolio in Q2 2026, its #257 holding.
  • First Heartland Consultants first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • First Heartland Consultants's Merck position peaked at $2.24M in Q2 2022.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on First Heartland Consultants's 13F filing for Q2 2026, filed 8 Jul 2026.